Takata M - Search Results

1

NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression.

Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, Goto Y, Shang WH, Kubodera M, Kato M, Takata M, Saida T, Kamata T. Yamaura M, et al. Among authors: takata m. Cancer Res. 2009 Mar 15;69(6):2647-54. doi: 10.1158/0008-5472.CAN-08-3745. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276355

2

Histopathological characteristics of malignant melanoma affecting mucous membranes: a unifying concept of histogenesis.

Saida T, Kawachi S, Takata M, Kurita H, Kurashina K, Kageshita T, Tonogi M, Okazaki Y, Yamane GY, Takubo K, Ueyama Y. Saida T, et al. Among authors: takata m. Pathology. 2004 Oct;36(5):404-13. doi: 10.1080/00313020412331282753. Pathology. 2004. PMID: 15370109

3

Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors.

Takata M, Suzuki T, Ansai S, Kimura T, Shirasaki F, Hatta N, Saida T. Takata M, et al. J Dermatol Sci. 2005 Oct;40(1):51-7. doi: 10.1016/j.jdermsci.2005.06.009. J Dermatol Sci. 2005. PMID: 16054806

4

Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas.

Takata M, Goto Y, Ichii N, Yamaura M, Murata H, Koga H, Fujimoto A, Saida T. Takata M, et al. J Invest Dermatol. 2005 Aug;125(2):318-22. doi: 10.1111/j.0022-202X.2005.23812.x. J Invest Dermatol. 2005. PMID: 16098043 Free article.

5

Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.

Yamaura M, Takata M, Miyazaki A, Saida T. Yamaura M, et al. Among authors: takata m. Arch Dermatol. 2005 Nov;141(11):1413-8. doi: 10.1001/archderm.141.11.1413. Arch Dermatol. 2005. PMID: 16301388

6

Early cancers of the skin: clinical, histopathological, and molecular characteristics.

Takata M, Saida T. Takata M, et al. Int J Clin Oncol. 2005 Dec;10(6):391-7. doi: 10.1007/s10147-005-0532-7. Int J Clin Oncol. 2005. PMID: 16369742 Review.

7

A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy.

Goto Y, Matsuzaki Y, Kurihara S, Shimizu A, Okada T, Yamamoto K, Murata H, Takata M, Aburatani H, Hoon DS, Saida T, Kawakami Y. Goto Y, et al. Among authors: takata m. Cancer Res. 2006 Apr 15;66(8):4443-9. doi: 10.1158/0008-5472.CAN-05-2505. Cancer Res. 2006. PMID: 16618771

8

High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi.

Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, Fujimoto A, Hatta N, Saida T. Ichii-Nakato N, et al. Among authors: takata m. J Invest Dermatol. 2006 Sep;126(9):2111-8. doi: 10.1038/sj.jid.5700366. Epub 2006 May 11. J Invest Dermatol. 2006. PMID: 16691193 Free article.

9

Genetic alterations in melanocytic tumors.

Takata M, Saida T. Takata M, et al. J Dermatol Sci. 2006 Jul;43(1):1-10. doi: 10.1016/j.jdermsci.2006.05.002. J Dermatol Sci. 2006. PMID: 16750612 Review.

10

Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas.

Murata H, Ashida A, Takata M, Yamaura M, Bastian BC, Saida T. Murata H, et al. Among authors: takata m. Cancer Sci. 2007 Jul;98(7):958-63. doi: 10.1111/j.1349-7006.2007.00496.x. Epub 2007 May 4. Cancer Sci. 2007. PMID: 17488338 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,231 results

Search Page

Filters